People Briefs: Elliott B. Grossbard

Elliott B. Grossbard has been named vice president of medical and regulatory affairs at California Biotechnology Inc. (Cal Bio) of Mountain View, Calif. His duties will include guiding products through the final stages of development and regulatory approval. Grossbard, 43, joins Cal Bio from HemaGen/PFC of San Francisco, where he had been vice president of medical affairs since 1990. From 1982 to 1990, he held a variety of positions at Genentech Inc. of South San Francisco, Calif. Grossbard re

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Elliott B. Grossbard has been named vice president of medical and regulatory affairs at California Biotechnology Inc. (Cal Bio) of Mountain View, Calif. His duties will include guiding products through the final stages of development and regulatory approval. Grossbard, 43, joins Cal Bio from HemaGen/PFC of San Francisco, where he had been vice president of medical affairs since 1990. From 1982 to 1990, he held a variety of positions at Genentech Inc. of South San Francisco, Calif.

Grossbard received his B.A. from Columbia College in 1969 and his M.D. from Columbia University in 1973. He did an internship and residency at Massachusetts General Hospital and then held several research positions at New York's Memorial Sloan-Kettering Cancer Center. He has also been a senior research physician at Hoffmann-La Roche Inc. of Nutley, N.J.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies